GooseheadInsurance.png
Goosehead Insurance, Inc. Announces First Quarter 2024 Results
April 24, 2024 16:10 ET | Goosehead Insurance, Inc.
–  Total Revenue Increased 11% and Core Revenue Grew 13% over the Prior-Year Period  ––  Total Written Premium increased 28% to $819 million over the Prior-Year Period  ––  Net Income of $1.8 million...
ContextLogic-Logo-2.png
ContextLogic to Announce First Quarter 2024 Results on May 8, 2024
April 24, 2024 16:10 ET | ContextLogic Inc.
SAN FRANCISCO, April 24, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ: WISH) today announced it will report its first quarter 2024 financial results after the close of market on Wednesday, May...
Fisher logo bw 022515.png
John B. Sanfilippo & Son, Inc. 3rd Quarter Fiscal Year 2024 Operating Results Conference Call
April 24, 2024 16:10 ET | John B. Sanfilippo & Son, Inc.
Elgin, IL, April 24, 2024 (GLOBE NEWSWIRE) -- John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS), a major processor and distributor of snack and recipe nut products, will hold its quarterly...
Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
April 24, 2024 16:05 ET | Supernus Pharmaceuticals, Inc.
ROCKVILLE, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of...
Nextnav logo.png
NextNav Announces Date for First Quarter 2024 Earnings Call
April 24, 2024 16:05 ET | NextNav
MCLEAN, Va., April 24, 2024 (GLOBE NEWSWIRE) -- NextNav (Nasdaq: NN), a leader in next generation positioning, navigation, timing (PNT) and 3D geolocation, today announced that it will release its...
tscan-logo.png
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
April 24, 2024 16:05 ET | TScan Therapeutics, Inc.
WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered...
BRKL-Bancorp-Logo-RGB-Color.jpg
Brookline Bancorp Announces First Quarter Results
April 24, 2024 16:05 ET | Brookline Bancorp, Inc.
Net Income of $14.7 million, EPS of $0.16 Quarterly Dividend of $0.135 BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Brookline Bancorp, Inc. (NASDAQ: BRKL) (the “Company”) today announced net income...
Appian 2021 (blue-white field).jpg
Appian To Announce First Quarter 2024 Financial Results on May 2
April 24, 2024 16:05 ET | Appian Corporation
MCLEAN, Va., April 24, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced that it will release financial results for the first quarter ended March 31, 2024, before the U.S. financial...
NVE Corporation Logo
NVE Schedules Conference Call on Fourth-Quarter and Fiscal Year Results
April 24, 2024 16:05 ET | NVE Corporation
EDEN PRAIRIE, Minn., April 24, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced that it plans to release its financial results for the quarter and fiscal year ended March 31, 2024...
Sensei_Logo_RGB_Logo_Full-Color.png
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting
April 24, 2024 16:05 ET | Sensei Biotherapeutics
BOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation...